Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Pharmaceutical Sciences
|
July 30, 2020
Assessing the Impact of Different Light Sources on Product Quality During Pharmaceutical Drug Product Manufacture - Fluorescent Versus Light-Emitting Diode Light
Walter Wasylaschuk, Brittany Pierce, Xiaoliu Geng, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 24, 2006
Identification of impurities in ivermectin bulk material by mass spectrometry and NMR
Christopher A Beasley, Tsang-Lin Hwang, Kyle Fliszar, et al.
The AAPS Journal
|
May 21, 2020
In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When-Workshop Summary Report
Sandra Suarez-Sharp, Andreas Abend, Thomas Hoffelder, et al.
Pharmaceutics
|
December 28, 2019
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory Perspectives
Mark McAllister, Talia Flanagan, Karin Boon, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 21, 2020
Development of an automated and High throughput UHPLC/MS based workflow for cleaning verification of potent compounds in the pharmaceutical manufacturing environment
Huaming Sheng, Dae Kim, Alexander S Chin, et al.
The AAPS Journal
|
April 7, 2022
DISSOLUTION PROFILE SIMILARITY ANALYSES-STATISTICAL PRINCIPLES, METHODS AND CONSIDERATIONS
Thomas Hoffelder, David Leblond, Leslie Van Alstine, et al.
The AAPS Journal
|
March 10, 2026
PQRI Workshop: Model-Informed Drug Development (MIDD) Approaches in Pediatric Formulation Development
Gilbert J Burckart, Susan Abdel-Rahman, Caleb Choi, et al.
Journal of Pharmaceutical Sciences
|
October 28, 2017
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and Commercialization
Haiyan Grady, David Elder, Gregory K Webster, et al.
AAPS Pharmscitech
|
November 28, 2013
Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 1: Predicting degradation related impurities and impurity considerations for pharmaceutical dosage forms
Karen M Alsante, Kim Huynh-Ba, Steven W Baertschi, et al.
The AAPS Journal
|
August 29, 2018
Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report
Sandra Suarez-Sharp, Michael Cohen, Filippos Kesisoglou, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Pharmaceutical Sciences
|
July 30, 2020
Assessing the Impact of Different Light Sources on Product Quality During Pharmaceutical Drug Product Manufacture - Fluorescent Versus Light-Emitting Diode Light
Walter Wasylaschuk, Brittany Pierce, Xiaoliu Geng, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 24, 2006
Identification of impurities in ivermectin bulk material by mass spectrometry and NMR
Christopher A Beasley, Tsang-Lin Hwang, Kyle Fliszar, et al.
The AAPS Journal
|
May 21, 2020
In Vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality: What, How, When-Workshop Summary Report
Sandra Suarez-Sharp, Andreas Abend, Thomas Hoffelder, et al.
Pharmaceutics
|
December 28, 2019
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory Perspectives
Mark McAllister, Talia Flanagan, Karin Boon, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 21, 2020
Development of an automated and High throughput UHPLC/MS based workflow for cleaning verification of potent compounds in the pharmaceutical manufacturing environment
Huaming Sheng, Dae Kim, Alexander S Chin, et al.
The AAPS Journal
|
April 7, 2022
DISSOLUTION PROFILE SIMILARITY ANALYSES-STATISTICAL PRINCIPLES, METHODS AND CONSIDERATIONS
Thomas Hoffelder, David Leblond, Leslie Van Alstine, et al.
The AAPS Journal
|
March 10, 2026
PQRI Workshop: Model-Informed Drug Development (MIDD) Approaches in Pediatric Formulation Development
Gilbert J Burckart, Susan Abdel-Rahman, Caleb Choi, et al.
Journal of Pharmaceutical Sciences
|
October 28, 2017
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and Commercialization
Haiyan Grady, David Elder, Gregory K Webster, et al.
AAPS Pharmscitech
|
November 28, 2013
Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 1: Predicting degradation related impurities and impurity considerations for pharmaceutical dosage forms
Karen M Alsante, Kim Huynh-Ba, Steven W Baertschi, et al.
The AAPS Journal
|
August 29, 2018
Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report
Sandra Suarez-Sharp, Michael Cohen, Filippos Kesisoglou, et al.
Page
of 3